T Cell-Dependent Affinity Maturation and Innate Immune Pathways Differentially Drive Autoreactive B Cell Responses in Rheumatoid Arthritis
Overview
Authors
Affiliations
Objective: Rheumatoid arthritis (RA) is characterized by the activation of B cells that produce anti-citrullinated protein antibodies (ACPAs) and rheumatoid factors (RFs), but the mechanisms by which tolerance is broken in these B cells remain incompletely understood. We undertook this study to investigate whether ACPA+ and RF+ B cells break tolerance through distinct molecular mechanisms.
Methods: We developed antigen-tetramers to isolate ACPA+ and RF+ B cells and performed single-cell RNA sequencing on 2,349 B cells from 6 RA patients and 1 healthy donor to analyze their immunoglobulin repertoires and transcriptional programs. Prominent immunoglobulins were expressed as monoclonal antibodies and tested for autoantigen reactivity.
Results: ACPA+ and RF+ B cells were enriched in the peripheral blood of RA patients relative to healthy controls. Characterization of patient-derived monoclonal antibodies confirmed ACPA and RF targeting of tetramer-specific B cells at both antigen-inexperienced and affinity-matured B cell stages. ACPA+ B cells used more class-switched isotypes and exhibited more somatic hypermutations relative to RF+ B cells, and these differences were accompanied by down-regulation of CD72 and up-regulation of genes that promote class-switching and T cell-dependent responses. In contrast, RF+ B cells expressed transcriptional programs that stimulate rapid memory reactivation through multiple innate immune pathways. Coexpression analysis revealed that ACPA+ and RF+ B cell-enriched genes belong to distinct transcriptional regulatory networks.
Conclusion: Our findings suggest that ACPA+ and RF+ B cells are imprinted with distinct transcriptional programs, which suggests that these autoantibodies associated with increased inflammation in RA arise from 2 different molecular mechanisms.
Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases.
Fehringer M, Vogl T J Transl Autoimmun. 2025; 10:100269.
PMID: 39877080 PMC: 11773492. DOI: 10.1016/j.jtauto.2025.100269.
Immune Repertoires in Various Dermatologic and Autoimmune Diseases.
Terhaar H, Jiminez V, Grant E, Collins C, Khass M, Yusuf N Genes (Basel). 2025; 15(12.
PMID: 39766858 PMC: 11675122. DOI: 10.3390/genes15121591.
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.
Holers V, Demoruelle K, Buckner J, James E, Firestein G, Robinson W Nat Rev Rheumatol. 2024; 20(10):601-613.
PMID: 39251771 DOI: 10.1038/s41584-024-01154-0.
Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice.
Nishide M, Shimagami H, Kumanogoh A Nat Rev Immunol. 2024; 24(11):781-797.
PMID: 38914790 DOI: 10.1038/s41577-024-01043-3.
Dunlap G, Wagner A, Meednu N, Wang R, Zhang F, Ekabe J Nat Commun. 2024; 15(1):4991.
PMID: 38862501 PMC: 11167034. DOI: 10.1038/s41467-024-49186-0.